Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Chronic Hepatitis C Genotype 1”

428 trials

Showing 20 of 428 results

Testing effectiveness (Phase 2)Study completedNCT00963885
What this trial is testing

RO5190591 (Danoprevir) in Combination With Pegasys and Copegus in Treatment-Naive Patients With Chronic Hepatitis C Genotype 1 Virus Infection

Who this might be right for
Hepatitis C, Chronic
Hoffmann-La Roche 229
Not applicableWithdrawnNCT00876174
What this trial is testing

Effects of Genotypes on Interferon Signaling in Chronic Hepatitis C

Who this might be right for
Chronic Hepatitis C
University of Nebraska
Not applicableStudy completedNCT04189627
What this trial is testing

The Effectiveness and Clinical Practice Use of Glecaprevir/Pibrentasvir in Adolescents With Chronic Hepatitis C Genotypes 1 to 6 in Russian Federation

Who this might be right for
Hepatitis C Virus (HCV)
AbbVie 99
Large-scale testing (Phase 3)Study completedNCT01754974
What this trial is testing

Safety and Efficacy Study of Peginterferon Lambda-1a vs. Peginterferon Alfa-2a, Plus Ribavirin in Subjects With Genotype 1 Hepatitis C

Who this might be right for
Hepatitis C Virus (HCV)
Bristol-Myers Squibb 40
Testing effectiveness (Phase 2)Study completedNCT01899092
What this trial is testing

Safety and Efficacy Study of Single Doses of TT-034 in Patients With Chronic Hepatitis C

Who this might be right for
Hepatitis C
Tacere Therapeutics, Inc. 9
Large-scale testing (Phase 3)Study completedNCT02032875
What this trial is testing

Phase III Daclatasvir, Sofosbuvir, and Ribavirin in Cirrhotic Participants and Participants Post-liver Transplant

Who this might be right for
Hepatitis C
Bristol-Myers Squibb 116
Large-scale testing (Phase 3)WithdrawnNCT01641666
What this trial is testing

Safety and Tolerability of Boceprevir in Combination With Peginterferon Alfa-2b Plus Ribavirin for the Treatment of Vietnamese Subjects With Chronic Hepatitis C Genotype 1 (P08599)

Who this might be right for
Chronic Hepatitis C
Merck Sharp & Dohme LLC
Not applicableStudy completedNCT01884402
What this trial is testing

Observational,Prospective Study to Develop and Validate a Prognostic Tool to Optimize Therapy in Patients With HCV G1/4

Who this might be right for
Hepatitis C, Chronic
Fundación Pública Andaluza para la gestión de la Investigación en Sevilla 770
Not applicableStudy completedNCT00709059
What this trial is testing

Efficacy of PegIntron and Rebetol in Previously Untreated Patients With Chronic Hepatitis C Infected With HCV Genotype 1/4/5/6 (Study P04243)

Who this might be right for
Hepatitis C, Chronic
Merck Sharp & Dohme LLC 538
Testing effectiveness (Phase 2)Study completedNCT00664625
What this trial is testing

A Single Ascending Dose Study of BMS-791325 in HCV Infected Subjects

Who this might be right for
Chronic Hepatitis C
Bristol-Myers Squibb 24
Testing effectiveness (Phase 2)Study completedNCT01726517
What this trial is testing

Safety and Efficacy of LDV/SOF Fixed-Dose Combination (FDC) ± Ribavirin in HCV Genotype 1 Subjects

Who this might be right for
Chronic Hepatitis C Virus
Gilead Sciences 100
Testing effectiveness (Phase 2)Study completedNCT01271790
What this trial is testing

Response-Guided Duration of Combination Therapy With GS-9451, Pegasys® and Copegus® With and Without Tegobuvir (GS-9190) in Previously Untreated Subjects With Genotype 1 Chronic Hepatitis C

Who this might be right for
Hepatitis C, Chronic
Gilead Sciences 245
Testing effectiveness (Phase 2)Study completedNCT00968357
What this trial is testing

Proof-of-concept Study to Evaluate the Safety and Immunomodulatory Effects of SCV 07 as Monotherapy or in Combination With Ribavirin in Noncirrhotic Subjects With Chronic Hepatitis C Who Have Relapsed

Who this might be right for
Chronic Hepatitis C
SciClone Pharmaceuticals 40
Testing effectiveness (Phase 2)Study completedNCT02262728
What this trial is testing

An Efficacy, Safety and Pharmacokinetics Study of Simeprevir, Daclatasvir and Sofosbuvir in Participants With Chronic Hepatitis C Virus Genotype 1 or 4 Infection and Decompensated Liver Disease

Who this might be right for
Hepatitis C, Chronic
Janssen Research & Development, LLC 40
Testing effectiveness (Phase 2)Study completedNCT00991289
What this trial is testing

Nitazoxanide Plus Ribavirin and Peginterferon for Therapy of Treatment Naive HCV Genotype 1 and HIV Coinfected Subjects

Who this might be right for
HIV InfectionHepatitis C Infection
National Institute of Allergy and Infectious Diseases (NIAID) 68
Large-scale testing (Phase 3)Study completedNCT01425203
What this trial is testing

The Effect of Boceprevir in Russian Participants Diagnosed With Chronic Hepatitis C Genotype 1 (P08160)

Who this might be right for
Chronic Hepatitis C Genotype 1
Merck Sharp & Dohme LLC 238
Large-scale testing (Phase 3)Study completedNCT02123654
What this trial is testing

UNITY 3: A Japanese Phase 3 Study of a Daclatasvir/Asunaprevir/BMS-791325 in Subjects With Genotype 1 Chronic Hepatitis C

Who this might be right for
Hepatitis C Virus Infection
Bristol-Myers Squibb 297
Testing effectiveness (Phase 2)Study completedNCT02349048
What this trial is testing

Study to Assess Efficacy, Safety, Tolerability and Pharmacokinetics of Simeprevir, Daclatasvir and Sofosbuvir in Treatment-naive Participants With Chronic Hepatitis C Virus Genotype 1 Infection

Who this might be right for
Hepatitis C Virus
Janssen Research & Development, LLC 68
Not applicableWithdrawnNCT00571714
What this trial is testing

Pilot Comparison of Standard Antiviral Therapy With and Without 12 Weeks of Betaine in Genotype 1 Naive Patients

Who this might be right for
Chronic Hepatitis C
University of Nebraska
Post-approval studies (Phase 4)Study completedNCT00926614
What this trial is testing

Efficacy of Actos Lipitor Pegasys & Ribavirin in CHC GT 1 Patients Who Relapsed or Nonresponded to Peg/Riba

Who this might be right for
Hepatitis c
Brooke Army Medical Center 20
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation